Skip to main content

Table 2 Univariate analysis with respect to overall survival (n = 135).

From: Phosphorylated Smad2 in Advanced Stage Gastric Carcinoma

Parameter Risk ratio 95% Confidence interval p-Value
P-Smad2 expression 1.650 1.005-2.710 0.048
   Low vs. high    
Morphologic feature 5.354 3.199-8.963 < 0.001
   Type 1, 2, and 3 vs. type 4    
Differentiation 3.883 2.020-7.463 < 0.001
   Intestinal-type vs. Diffuse-type    
Lymph node metastasis (Japanese classification) 3.269 1.978-5.403 < 0.001
   N0 and N1 vs. N2 and N3    
Peritoneal dissemination 5.534 3.056-8.738 < 0.001
   Negative vs. positive    
Peritoneal cytology 5.937 3.468-10.166 < 0.001
   Negative vs. positive    
Lymphatic invasion 2.055 1.234-3.421 0.006
   Ly0 and ly1 vs. ly2 and ly3    
Clinical Stage 6.901 4.088-11.651 < 0.001
   I, II, and III vs. IV